Beta-amyloid inhibits NOS activity by subtracting NADPH availability

Area of Science:

• Neuroscience
• Biochemistry
• Molecular Biology

Background:

• Alzheimer's disease (AD) is linked to amyloid beta (Abeta) peptides.
• Nitric oxide synthases (NOS) play crucial roles in neuronal and endothelial functions.
• Dysregulation of NOS activity is implicated in neurodegenerative disorders.

Purpose of the Study:

• To investigate the inhibitory effects of amyloid beta peptides on constitutive nitric oxide synthases (NOS-I and NOS-III).
• To elucidate the molecular mechanism underlying NOS inhibition by Abeta fragments, specifically Abeta25-35.
• To assess the physiological relevance of Abeta-induced NOS inhibition in cellular models.

Main Methods:

• Cell-free assays using purified NOS isoforms and synthetic Abeta peptides (Abeta1-42, Abeta25-35).
• Spectroscopic techniques (optical, fluorescence, NMR) to study Abeta-NADPH interactions.
• Cellular studies using rat neuronal-like PC12 and glioma C6 cell lines to measure NOS activity (DAF-2DA detection) and gene expression (NOS-II mRNA).

Main Results:

• Abeta1-42 and Abeta25-35 significantly inhibited NOS-I and NOS-III activity in cell-free systems.
• The inhibition by soluble Abeta25-35 was NADPH-dependent and involved direct interaction with the cofactor.
• Internalization of Abeta25-35 into PC12 and C6 cells impaired constitutive NOS activity and led to increased NOS-II mRNA expression in C6 cells.

Conclusions:

• Amyloid beta fragments directly impair constitutive NOS activity through NADPH binding.
• This Abeta-induced NOS dysfunction represents a novel molecular mechanism potentially contributing to Alzheimer's disease pathogenesis.
• Findings highlight the cross-talk between amyloid pathology and nitric oxide signaling in the brain.